Worst of Reverse Convertible

Symbol: MLURCH
ISIN: CH1273041611
Issuer:
Raiffeisen

Chart

    
Bid 89.16
    
Ask 0.00
Created with Highcharts 8.0.009:3010:0010:3011:0011:3012:0012:3013:0013:3014:0014:3015:0015:3016:0016:3017:000255075100

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 89.27
Diff. absolute / % 1.69 +1.92%

Determined prices

Last Price 82.33 Volume 9,000
Time 11:22:00 Date 07/04/2025

More Product Information

Core Data

Name Worst of Reverse Convertible
ISIN CH1273041611
Valor 127304161
Symbol MLURCH
Quotation in percent Yes
Coupon p.a. 9.30%
Coupon Premium 4.84%
Coupon Yield 4.46%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 20/06/2023
Date of maturity 20/06/2025
Last trading day 12/06/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Dirty
Issuer Raiffeisen

Key data

Sideways yield p.a. -

market maker quality Date: 24/04/2025

Average Spread -
Last Best Bid Price 88.18 %
Last Best Ask Price - %
Last Best Bid Volume 250,000
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 USD
Average Sell Value 0 USD
Spreads Availability Ratio 0.00%
Quote Availability 100.00%

Underlyings

Name Pfizer Inc. Johnson & Johnson Merck & Co. Inc.
ISIN US7170811035 US4781601046 US58933Y1055
Price 20.13 EUR 134.85 EUR 72.60 EUR
Date 27/04/25 19:04 27/04/25 19:04 27/04/25 19:04
Cap 38.97 USD 160.01 USD 110.71 USD
Distance to Cap -16.615 -4.65 -32.01
Distance to Cap in % -74.32% -2.99% -40.67%
Is Cap Level reached No No No
Barrier 19.49 USD 80.01 USD 55.36 USD
Distance to Barrier 2.865 75.35 23.34
Distance to Barrier in % 12.82% 48.50% 29.66%
Is Barrier reached No No No

Cookie notification


Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.